Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Capital Leases: 2024

Historic Capital Leases for Vanda Pharmaceuticals (VNDA) over the last 1 years, with Dec 2024 value amounting to $3.1 million.

  • Vanda Pharmaceuticals' Capital Leases was N/A to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2024, which is N/A change from last year.
  • As of FY2024, Vanda Pharmaceuticals' Capital Leases stood at $3.1 million.
  • In the past 5 years, Vanda Pharmaceuticals' Capital Leases registered a high of $3.1 million during FY2024, and its lowest value of $3.1 million during FY2024.
  • Its 1-year average for Capital Leases is $3.1 million, with a median of $3.1 million in 2024.